AMPCliff: quantitative definition and benchmarking of activity cliffs in antimicrobial peptides
Kewei Li, Yuqian Wu, Yinheng Li, Yutong Guo, Yan Wang, Yiyang Liang,, Yusi Fan, Lan Huang, Ruochi Zhang, Fengfeng Zhou

TL;DR
This paper introduces AMPCliff, a framework for defining and benchmarking activity cliffs in antimicrobial peptides, revealing their prevalence and evaluating prediction models with ESM2 showing the best performance.
Contribution
It provides a novel quantitative definition and benchmarking dataset for activity cliffs in AMPs, and evaluates various machine learning and language models for prediction.
Findings
Significant prevalence of activity cliffs in AMPs.
ESM2 outperforms other models in detecting activity cliffs.
Current models have limited accuracy in predicting MIC values.
Abstract
Since the mechanism of action of drug molecules in the human body is difficult to reproduce in the in vitro environment, it becomes difficult to reveal the causes of the activity cliff phenomenon of drug molecules. We found out the AC of small molecules has been extensively investigated but limited knowledge is accumulated about the AC phenomenon in peptides with canonical amino acids. Understanding the mechanism of AC in canonical amino acids might help understand the one in drug molecules. This study introduces a quantitative definition and benchmarking framework AMPCliff for the AC phenomenon in antimicrobial peptides (AMPs) composed by canonical amino acids. A comprehensive analysis of the existing AMP dataset reveals a significant prevalence of AC within AMPs. AMPCliff quantifies the activities of AMPs by the MIC, and defines 0.9 as the minimum threshold for the normalized BLOSUM62…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAntimicrobial Peptides and Activities · vaccines and immunoinformatics approaches · Biochemical and Structural Characterization
MethodsAdversarial Model Perturbation
